IO102-IO103
IO102-IO103-013 / KEYNOTE-D18
Phase 3 small_molecule active
Quick answer
IO102-IO103 for Metastatic Melanoma is a Phase 3 program (small_molecule) at IO Biotech with 1 ClinicalTrials.gov record(s).
Program details
- Company
- IO Biotech
- Indication
- Metastatic Melanoma
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active